L. Kost

Targeted DNA methylation profiling reveals epigenetic signatures in peanut allergy

K. Nadeau, Xiaorui Han, Xiaoying Zhou, 2021, JCI insight.

Transitioning from epicutaneous to oral peanut immunotherapy

S. Sindher, W. Collins, R. Chinthrajah, 2023, Frontiers in Allergy.

CD8+ T cell differentiation status correlates with the feasibility of sustained unresponsiveness following oral immunotherapy

R. Tibshirani, K. Nadeau, M. Tsai, 2022, Nature Communications.

Co-sensitization to the three non-homologous major cashew allergens Ana o 1, Ana o 2 and Ana o 3 is caused by IgE cross-reactivity.

C. Radauer, K. Hoffmann‐Sommergruber, M. Bublin, 2022, Journal of investigational allergology & clinical immunology.

Immune changes beyond Th2 pathways during rapid multifood immunotherapy enabled with omalizumab

K. Nadeau, S. Galli, H. Maecker, 2021, Allergy.

Peanut allergy: risk factors, immune mechanisms, and best practices for oral immunotherapy success

K. Nadeau, J. Tirumalasetty, Suzanne M Barshow, 2023, Expert review of clinical immunology.

Identification of Pru du 6 as a potential marker allergen for almond allergy

K. Nadeau, M. Bublin, H. Breiteneder, 2020, Allergy.

Detection of gut and mucosal peptides through TOMAHAQ in healthy individuals

C. Akdis, Aashaq Shah, A. Heider, 2023, Allergy.